These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 2992664

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effect of highly selective inhibitors of the uptake of noradrenaline or 5-hydroxytryptamine on TRH-induced hyperthermia in mice.
    Pawłowski L, Kwiatek H.
    Psychopharmacology (Berl); 1983; 81(1):48-53. PubMed ID: 6138792
    [Abstract] [Full Text] [Related]

  • 8. Evidence for alpha 1-adrenergic stimulatory control of in vitro release of immunoreactive thyrotropin-releasing hormone from rat median eminence: in vivo corroboration.
    Tapia-Arancibia L, Arancibia S, Astier H.
    Endocrinology; 1985 Jun; 116(6):2314-9. PubMed ID: 2986944
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Naloxone potentiation of novelty-induced hypoalgesia: characterization of the alpha-noradrenergic receptor subtype.
    Rochford J, Dawes P, Stewart J.
    Pharmacol Biochem Behav; 1993 Feb; 44(2):381-6. PubMed ID: 8383341
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. TRH-induced antinociception: interaction with the opioid systems?
    Reny-Palasse V, Poncet J, Rips R.
    Gen Pharmacol; 1987 Feb; 18(2):179-83. PubMed ID: 3032733
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Determination of α(2)-adrenoceptor and imidazoline receptor involvement in augmentation of morphine and oxycodone analgesia by agmatine and BMS182874.
    Bhalla S, Rapolaviciute V, Gulati A.
    Eur J Pharmacol; 2011 Jan 25; 651(1-3):109-21. PubMed ID: 21114998
    [Abstract] [Full Text] [Related]

  • 16. The effect of thyrotropin releasing hormone and morphine on gastrointestinal transit.
    Pillai NP, Bhargava HN.
    Peptides; 1984 Jan 25; 5(6):1055-9. PubMed ID: 6099556
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Monoaminergic antagonists which block naloxone-induced release of luteinizing hormone bind selectively to hypothalamic opiate receptors.
    Blank MS, Diez JA, Roberts DL.
    Brain Res; 1983 Nov 21; 279(1-2):153-8. PubMed ID: 6315167
    [Abstract] [Full Text] [Related]

  • 19. Participation of an alpha 2-mediated mechanism in the production of forced swimming-stress induced analgesia in mice.
    Tokuyama S, Takahashi M, Kaneto H.
    J Pharmacobiodyn; 1991 Jun 21; 14(6):357-61. PubMed ID: 1664461
    [Abstract] [Full Text] [Related]

  • 20. Thyrotropin releasing hormone and naloxone attenuate the antihypertensive action of central alpha 2-adrenoceptor stimulation through different mechanisms.
    Kunos G, Newman F, Farsang C, Ungar W.
    Endocrinology; 1984 Dec 21; 115(6):2481-3. PubMed ID: 6094160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.